These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 22989552)
1. Two drugs with paradoxical effects on liver regeneration through antiangiogenesis and antifibrosis: Losartan and Spironolactone: a pharmacologic dilemma on hepatocyte proliferation. Parlakgumus A; Colakoglu T; Kayaselcuk F; Colakoglu S; Ezer A; Calıskan K; Karakaya J; Yildirim S J Surg Res; 2013 Jan; 179(1):60-5. PubMed ID: 22989552 [TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic response after 70% hepatectomy and its relationship with hepatic regeneration and angiogenesis in rats. Dogrul AB; Colakoglu T; Kosemehmetoglu K; Birben E; Yaman E; Gedikoglu G; Abbasoglu O Surgery; 2010 Feb; 147(2):288-94. PubMed ID: 20004434 [TBL] [Abstract][Full Text] [Related]
3. Erythropoietin promotes hepatic regeneration after extended liver resection in rats. Schmeding M; Boas-Knoop S; Lippert S; Ruehl M; Somasundaram R; Dagdelen T; Neuhaus P; Neumann UP J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1125-31. PubMed ID: 18086112 [TBL] [Abstract][Full Text] [Related]
4. Single dose of anti-transforming growth factor-beta1 monoclonal antibody enhances liver regeneration after partial hepatectomy in biliary-obstructed rats. Deneme MA; Ok E; Akcan A; Akyildiz H; Soyuer I; Muhtaroglu S J Surg Res; 2006 Dec; 136(2):280-7. PubMed ID: 17046790 [TBL] [Abstract][Full Text] [Related]
5. Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. Terada S; Ota S; Kobayashi M; Kobayashi T; Mifune Y; Takayama K; Witt M; Vadalà G; Oyster N; Otsuka T; Fu FH; Huard J J Bone Joint Surg Am; 2013 Jun; 95(11):980-8. PubMed ID: 23780535 [TBL] [Abstract][Full Text] [Related]
6. Role of transforming growth factor-beta1 (TGF-beta1) in endotoxin-induced hepatic failure after extensive hepatectomy in rats. Yoshimoto N; Togo S; Kubota T; Kamimukai N; Saito S; Nagano Y; Endo I; Sekido H; Nagashima Y; Shimada H J Endotoxin Res; 2005; 11(1):33-9. PubMed ID: 15826376 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors. Yayama K; Sugiyama K; Miyagi R; Okamoto H Biol Pharm Bull; 2007 Mar; 30(3):591-4. PubMed ID: 17329864 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II regulates liver regeneration via type 1 receptor following partial hepatectomy in mice. Yayama K; Miyagi R; Sugiyama K; Sugaya T; Fukamizu A; Okamoto H Biol Pharm Bull; 2008 Jul; 31(7):1356-61. PubMed ID: 18591774 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats. Ueda S; Yamanoi A; Hishikawa Y; Dhar DK; Tachibana M; Nagasue N Lab Invest; 2003 Nov; 83(11):1595-603. PubMed ID: 14615413 [TBL] [Abstract][Full Text] [Related]
11. The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats. Siregar S; Rulianov R; Ksatriapraja RA; Stefanus D F1000Res; 2022; 11():831. PubMed ID: 38046538 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. Shimizu H; Miyazaki M; Wakabayashi Y; Mitsuhashi N; Kato A; Ito H; Nakagawa K; Yoshidome H; Kataoka M; Nakajima N J Hepatol; 2001 May; 34(5):683-9. PubMed ID: 11434614 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl₄-Induced Skeletal Muscle Injury. Hwang OK; Park JK; Lee EJ; Lee EM; Kim AY; Jeong KS Int J Mol Sci; 2016 Feb; 17(2):227. PubMed ID: 26867195 [TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin-1 receptor blockade in cirrhotic liver resection. Bahde R; Kebschull L; Stöppeler S; Zibert A; Siaj R; Hölzen JP; Minin E; Schmidt HH; Spiegel HU; Palmes D Liver Int; 2011 May; 31(5):642-55. PubMed ID: 21457437 [TBL] [Abstract][Full Text] [Related]
15. Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination. Piecha G; Koleganova N; Gross ML; Geldyyev A; Adamczak M; Ritz E Am J Physiol Renal Physiol; 2008 Jul; 295(1):F137-44. PubMed ID: 18434388 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1). Takahashi T; Ono H; Ono Y; Ishimitsu T; Matsuoka H Int Heart J; 2007 Sep; 48(5):637-47. PubMed ID: 17998773 [TBL] [Abstract][Full Text] [Related]
18. The effect of the angiotensin II receptor, type 1 receptor antagonists, losartan and telmisartan, on thioacetamide-induced liver fibrosis in rats. Czechowska G; Celinski K; Korolczuk A; Wojcicka G; Dudka J; Bojarska A; Madro A; Brzozowski T J Physiol Pharmacol; 2016 Aug; 67(4):575-586. PubMed ID: 27779478 [TBL] [Abstract][Full Text] [Related]
19. [Effect of losartan on the expressions of TGF-beta1, p-Smad2/3, and Smad7 in the remnant renal tissues of 5/6 nephrectomized rats]. Ning WB; Hu J; Tao LJ; Liu CY; Sun J; Xiao Y; Jia AJ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):1007-12. PubMed ID: 18182718 [TBL] [Abstract][Full Text] [Related]
20. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology. Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]